ConductScience.org, home

Library / Trial comparisons

Open Group vs Masked Group: Number of Infants Experiencing Neonatal Encephalopathy (Primary Outcome Component)

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.0007230.0002810.00186wilsonClinicalTrials.gov
Risk in group 20.0008970.0003830.0021wilsonClinicalTrials.gov
Risk difference, group 1 minus group 2-0.000174-0.001450.00107newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 20.8060.2173logClinicalTrials.gov
Odds ratio, group 1 over group 20.8060.2163logClinicalTrials.gov
Number needed to treat, for one fewer participant with the outcome on Open Group than on Masked Group5,760from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Open Group
S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines
45,532OG000ClinicalTrials.gov
Group 2Masked GroupThe masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.55,576OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypePRIMARYClinicalTrials.gov
TitleNumber of Infants Experiencing Neonatal Encephalopathy (Primary Outcome Component)ClinicalTrials.gov
DescriptionNeonatal encephalopathy experienced between delivery and dischargeClinicalTrials.gov
Time frameDelivery through hospital dischargeClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleFetal ST Segment and T Wave Analysis in LaborClinicalTrials.gov
NCT numberNCT01131260ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsPregnancy, Obstetric Labor, ParturitionClinicalTrials.gov
Interventionsfetal STAN monitorClinicalTrials.gov
Lead sponsorThe George Washington University Biostatistics CenterClinicalTrials.gov
Results first posted2019-04-05ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT01131260?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.